Navigation Links
Quest Diagnostics To Speak At The Oppenheimer 20th Annual Healthcare Conference
Date:11/2/2009

The statements in this press release which are not historical facts may be forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date that they are made and which reflect management's current estimates, projections, expectations or beliefs and which involve risks and uncertainties that could cause actual results and outcomes to be materially different. Risks and uncertainties that may affect the future results of the company include, but are not limited to, adverse results from pending or future government investigations, lawsuits or private actions, the competitive environment, changes in government regulations, changing relationships with customers, payers, suppliers and strategic partners and other factors discussed in "Business," in "Risk Factors," "Cautionary Factors that May Affect Future Results," "Legal Proceedings," "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Quantitative and Qualitative Disclosures About Market Risk" in the company's 2008 Annual Report on Form 10-K and "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Quantitative and Qualitative Disclosures About Market Risk" and "Risk Factors" in the company's 2009 Quarterly Reports on Form 10-Q and other items throughout the Form 10-K and the company's 2009 Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.

    Contacts:
    Kathleen Valentine (Investors):   973-520-2900
    Wendy Bost (Media):               973-520-2800

SOURCE Quest Diagnostics


'/>"/>
SOURCE Quest Diagnostics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. For the First Time, Blood Donors May Answer Their Health History Questions Online From the Privacy of Their Home or Office
2. FDA Issues Another Emergency Use Authorization for Commercial H1N1 Flu Test to Quest Diagnostics Focus Diagnostics
3. Dynatronics Will Request Hearing With Nasdaq Regarding Listing Status
4. Quest Diagnostics Brings Genetic Testing for Plavix(R) Response to Coronary Stent Patients at Scripps Health
5. Stemedica Requests Pre-IND Meeting With FDA
6. NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
7. Quest Diagnostics Introduces First Commercial Laboratory Test for Identifying the H1N1 Swine Flu Virus
8. ImQuest BioSciences Receives Phase I SBIR Grant to Develop a Novel Hepatitis C Virus Therapeutic Agent
9. Quest Diagnostics ClariSure(TM) Postnatal Molecular Test Receives Clinical Laboratory Approval from New York State
10. ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410
11. Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)...  EndoChoice today announced the launch of its initial ... which will represent 25.6% of its outstanding common stock ... corporation in connection with the offering. The initial ... $15 and $17 per share. The underwriters for the ... up to an additional 937,500 shares of EndoChoice common ...
(Date:5/26/2015)... LONDON , May 26, 2015 ... that technology,s commercial potential ,What,s the future of ... and commercial predictions from 2015. Stay ahead there ... tests, you explore sales results, R&D, opportunities and ... visiongain shows you what,s possible for ...
(Date:5/26/2015)... , May 26, 2015  Array BioPharma ... its Chief Executive Officer, Ron Squarer , ... Conference in New York City. The public is welcome ... on the Array BioPharma website.Event: Jefferies 2015 Global ... 2015Time:1:30 p.m. Eastern Time Webcast: www.arraybiopharma.com  About Array ...
Breaking Medicine Technology:EndoChoice Announces Launch of Its Initial Public Offering 2Cell-Based Assays: World Industry and Market Prospects 2015-2025 2Cell-Based Assays: World Industry and Market Prospects 2015-2025 3Cell-Based Assays: World Industry and Market Prospects 2015-2025 4Cell-Based Assays: World Industry and Market Prospects 2015-2025 5Cell-Based Assays: World Industry and Market Prospects 2015-2025 6Cell-Based Assays: World Industry and Market Prospects 2015-2025 7
... WIRE)--Jun 25, 2007 - HepaLife Technologies, Inc.,(OTCBB: ... that new,data presented at an international influenza ... line outperforms,current cell technologies at replicating human ... step towards the production of,a cell-culture based ...
... of patients receiving highest dose,achieves A1c with ... /PRNewswire-FirstCall/ -- According to,findings presented today at ... Association (ADA) in Chicago, Illinois, the,investigational treatment ... analog under development by Novo Nordisk for ...
Cached Medicine Technology:HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 2HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 3HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 4HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 5HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 6Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog,Liraglutide, Brings Patients to A1c Target 2Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog,Liraglutide, Brings Patients to A1c Target 3Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog,Liraglutide, Brings Patients to A1c Target 4
(Date:5/26/2015)... CA (PRWEB) May 26, 2015 Irwin ... launched and directed a hospital-wide Patient Blood Management (PBM) ... that reduced overall blood usage by more than 60 ... , Covered in detail in an article in ... resulted in substantially reduced perioperative red cell loss, less ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Two addiction ... joined Dr. Marissa Pei on a CNBC ... focusing on addiction. Aired on KCAA AM 1050, the ... Duncan, marriage and family therapist, as they discuss current ... to affect more than 23.5 million Americans. The program, ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Synthetic ... According to an article published by International ... marijuana (dubbed K2, Spice, and black mamba) causes ... of these synthetic substances make it nearly impossible ... patients’ use of the substance due to the ...
(Date:5/26/2015)... Indosoft, Inc ., developer of ... DMi Partners contact center to Q-Suite 5.8 call ... contact center ACD system to drop Asterisk 1.4 support. ... trunk features as diversion headers, added Lyra support via ... to warm transfers to improve information handling ...
(Date:5/26/2015)... 26, 2015 i2i Systems, the leader ... more than 15 years, has earned 2014 Patient Centered ... Quality Assurance (NCQA) for its flagship product i2iTracks ... of the work we have done to create healthier ... the acknowledgement from NCQA once again,” said Janice Nicholson, ...
Breaking Medicine News(10 mins):Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 2Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 3Health News:Anaheim Lighthouse Staff Joined Dr. Marissa Pei’s in a Conversation on Drug and Alcohol Addiction 2Health News:Anaheim Lighthouse Staff Joined Dr. Marissa Pei’s in a Conversation on Drug and Alcohol Addiction 3Health News:Synthetic Cannabinoids Can Cause Psychotic Episodes; Doctors at a Loss for Treatment 2Health News:Synthetic Cannabinoids Can Cause Psychotic Episodes; Doctors at a Loss for Treatment 3Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 3Health News:i2iTracks Earns NCQA 2014 PCMH Prevalidation 2Health News:i2iTracks Earns NCQA 2014 PCMH Prevalidation 3
... Reportedly Claims the Life of a Pop Icon , , ... in grieving the loss of pop icon Michael Jackson. His apparent ... SCA is a leading cause of death worldwide. , ... cardiac arrest is not uncommon," said Bobby Khan, MD, Chairman of ...
... number of deaths and injuries associated with Hawaiian air tours ... according to a new study by researchers from the Johns ... and Policy. However, the proportion of crashes that resulted ... to an increase in crashes that resulted from poor visibility, ...
... DETROIT, June 25 Caraco Pharmaceutical Laboratories, Ltd. (NYSE ... at the request of the Food and Drug Administration, ... Michigan facilities. The seizure also included ingredients held at ... Caraco,s Detroit facility, completed in May 2009, found unresolved ...
... Calif., June 25 A U.S. District Court judge ... halt a proposed $2 cut in wages for the state,s 400,000 ... cuts in all California counties that were planning on passing the ... , The injunction, issued by federal judge Claudia Wilken, was in ...
... Inc., maker of BladderScan(R) bladder volume instruments and ... Kendall Stever as Chief Financial Officer ("CFO"). ... of the Company,s global financial affairs, including day ... Washington State, taxation, investor relations as well as ...
... mind,s eye, an arm or hand changes shape, study finds, ... club and your brain may do more than look for an ... tools to be extensions of the body. , The mere act ... of a subject,s arm," said Lucilla Cardinali, a graduate student in ...
Cached Medicine News:Health News:Sudden Cardiac Arrest Foundation Mourns the Loss of Michael Jackson 2Health News:Sightseeing helicopter crashes in Hawaii decrease following FAA regulations 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Action 2Health News:Verathon Inc. Appoints Kendall Stever as Chief Financial Officer 2Health News:Grab a Tool and Change Your Brain 2
... to remove a cast from an arm or ... patients are cut or burned by the cast ... professionals to remove any cast with confidence. This ... cuts and burns from the cast saw and ...
... choice plays an important part in ... particularly where reduced capsule formation, inflammation ... considerations. GORE-TEX Suture, a nonabsorbable, ePTFE ... characteristics sought by a variety of ...
... GORE-TEX ACUSEAL Cardiovascular Patch ... it to "seal" around penetrating ... bleeding by as much as ... with improved suture retention, multi-directional ...
... Vascular Grafts have met the challenges ... Recognized for exceptional performance and quality, ... renowned surgeons worldwide. These grafts require ... spread of infection, and ensure utmost ...
Medicine Products: